vimarsana.com

Page 5 - Stern Ir Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Longeveron Receives Intent to Grant Notice from the European Patent Office for Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy Through Levels of Vascular Biomarker

MIAMI, Aug. 25, 2022 Longeveron Inc. , a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, today announced that. | August 25, 2022

United statesElsie yauEuropean patent officeDrug administrationCompany quarterly reports on formLongeveron incExchange commissionEuropean patent organizationStern ir incGlobenewswire incPatent officeVascular endothelial growth factorInterim chief executive officerChief medical officerMonitoring efficacyAllogeneic mesenchymal stem cell therapy

Longeveron to Announce Second Quarter 2022 Financial

Live conference call on Friday, August 12 at 8:30 a.m. EST.

United statesElsie yauStern ir incLongeveron or companyLongeveron incDial in numberReplay dial in numberAging frailtyAcute respiratory distress syndromeNasdaq lgvn

Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy

- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support continued development of DB-020 as a. | June 28, 2022

United statesDanny rischinJulie seidelJohn leeLaurence reidBen panizzaChris raileyDivision of cancer medicineExchange commissionStern ir incNeck cancer centreChief development officerAmerican speech language hearing associationSpeech intelligibility indexCancer medicineMedical oncology

Werewolf Therapeutics Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Highlights

24.03.2022 - -Closed upsized IPO in May 2021 raising $120 million in gross proceeds- -Announced clinical trial collaboration with Merck for WTX-124 INDUKINETM program- -Reported positive preclinical data at SITC demonstrating the potential to drive targeted .

United statesUnited kingdomRandi isaacsAmeeta chatterjeeChulani karunatilakeEllen lubmanDanielj hicklinJonathanm nugentMike shermanCompany board of directorsCompany contactCompany or werewolf nasdaqScientific communicationsAmerican society of hematologyExchange commissionStern ir inc

Decibel Therapeutics Reports on Continued Progress of Lead

- Podium presentation at Association for Research in Otolaryngology Annual MidWinter Meeting highlighting DB-OTO dose-ranging studies with expression.

United statesJulie seidelJohn leeChris raileyRegeneron pharmaceuticalsMidwinter meeting of the association for researchExchange commissionStern ir incAssociation for researchOtolaryngology annual midwinter meetingAnnual midwinter meetingChief development officerDecibel therapeuticsPrivate securities litigation reform actQuarterly reportNasdaq dbtx

vimarsana © 2020. All Rights Reserved.